Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
0.494
+0.004 (0.75%)
At close: Nov 20, 2024, 4:00 PM
0.481
-0.013 (-2.71%)
After-hours: Nov 20, 2024, 7:59 PM EST
Amarin Corporation Employees
Amarin Corporation had 275 employees as of December 31, 2023. The number of employees decreased by 90 or -24.66% compared to the previous year.
Employees
275
Change (1Y)
-90
Growth (1Y)
-24.66%
Revenue / Employee
$876,440
Profits / Employee
-$143,076
Market Cap
203.37M
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
SOPHiA GENETICS | 430 |
MacroGenics | 339 |
Inhibrx Biosciences | 172 |
Molecular Partners AG | 168 |
Acrivon Therapeutics | 61 |
Lexeo Therapeutics | 58 |
Sera Prognostics | 57 |
Orchestra BioMed Holdings | 56 |
AMRN News
- 1 day ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 21 days ago - Amarin Corporation plc (AMRN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting - GlobeNewsWire
- 3 months ago - Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress - GlobeNewsWire
- 4 months ago - Amarin Corporation plc (AMRN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal - GlobeNewsWire
- 4 months ago - Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024 - GlobeNewsWire